New hope for lymphoma patients who failed standard treatments?
Disease control
Not yet recruiting
This study is testing a drug called pirtobrutinib in 40 adults with mature B-cell lymphoma whose cancer got worse or who had side effects from earlier BTK inhibitor treatments. The goal is to see if the drug can shrink tumors or slow the disease. Participants will take the drug a…
Sponsor: Ou Bai, MD/PHD • Aim: Disease control
Last updated May 15, 2026 11:56 UTC